CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade

por von Roemeling, Christina, Yegorov, Oleg, Yang, Changlin, Klippel, Kelena, Russell, Rylynn, Trivedi, Vrunda, Bhatia, Alisha, Doonan, Bently, Carpenter, Savannah, Ryu, Daniel, Grippen, Adam, Futch, Hunter, Ran, Yong, Hoang-Minh, Lan, Weidert, Frances, Golde, Todd, Mitchell, Duane
Publicado 2023